JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Narayan Saraf as Chief Financial Officer of the company w.e.f. January 30, 2026.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed the stock exchange that Mr. Narayan Saraf, the company's Chief Financial Officer, has resigned from his position. His resignation will take effect from January 30, 2026. As CFO, he was a Key Managerial Personnel overseeing the company's financial strategy, reporting, and compliance functions. The company has not yet announced a successor or the reason for his departure in this filing.
A CFO exit can create short-term uncertainty around financial leadership and continuity, especially at a listed pharma company. Investors should watch for the company's next announcement regarding an interim arrangement or permanent successor, which will signal whether the transition is being managed smoothly.